Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2025
Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis.
Journal: Frontiers in oncology
Published: June 07, 2021
Metabolic Syndrome and Insulin Resistance in Schoolchildren From a Developing Country.
Journal: Frontiers in nutrition
Published: October 28, 2019
Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature.
Journal: Breast cancer research : BCR
Published: October 16, 2019
ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization.
ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization.
Journal: Molecular endocrinology (Baltimore, Md.)
Published: August 18, 2016
Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Journal: Oncotarget
Published: February 05, 2016
Carotenoid Nanovector for Efficient Therapeutic Gene Knockdown of Transcription Factor FOXC1 in Liver Cancer.
Journal: Bioconjugate chemistry
Published: January 01, 2016
Real-time Imaging of the Resection Bed Using a Handheld Probe to Reduce Incidence of Microscopic Positive Margins in Cancer Surgery.
Journal: Cancer research
Published: September 17, 2015
Intraoperative optical coherence tomography for assessing human lymph nodes for metastatic cancer.
Journal: BMC cancer
Published: July 21, 2015
FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer.
Journal: Cell reports
Published: April 06, 2015
Last Updated: 09/26/2026